PuSH - Publication Server of Helmholtz Zentrum München

11 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Hess, J. et al.: A five-microRNA signature predicts survival and disease control of patients with head and neck cancer negative for HPV-infection. Clin. Cancer Res. 25, 1505-1516 (2019)
2.
Baumann, M.* et al.: MPV17 mutations in juvenile- and adult-onset axonal sensorimotor polyneuropathy. Clin. Genet. 95, 182-186 (2018)
3.
Combs, S.E. et al.: Re-irradiation of recurrent gliomas: Pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK). Cancer Med. 7, 1742-1749 (2018)
4.
De-Colle, C.* et al.: SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy. Radiother. Oncol. 126, 125-131 (2018)
5.
Linge, A.* et al.: Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC. Radiother. Oncol. 127, 27-35 (2018)
6.
Schmidt, S.* et al.: Development and validation of a gene signature for patients with head and neck squamous cell carcinomas treated by postoperative radio(chemo)therapy. Clin. Cancer Res. 24, 1364-1374 (2018)
7.
Stangl, S. et al.: Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Int. J. Cancer 142, 1911-1925 (2018)
8.
Leger, S.* et al.: A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling. Sci. Rep. 7:13206 (2017)
9.
Trompier, F.* et al.: Overview of physical dosimetry methods for triage application integrated in the new European network RENEB. Int. J. Radiat. Biol. 93, 65-74 (2017)
10.
Linge, A.* et al.: HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Radiother. Oncol. 121, 364-373 (2016)
11.
Tinhofer, I.* et al.: Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation. Eur. J. Cancer 57, 78-86 (2016)